VG Life Sciences Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Cash & Short Term Investments
7.20
5.80
6.10
713.90
34.00
Other Current Assets
9.10
3.00
3.00
75.50
212.30
Total Current Assets
16.40
8.80
9.10
789.40
246.30
Total Investments and Advances
100.00
100.00
100.00
-
-
Long-Term Note Receivable
9.50
9.50
9.50
-
-
Intangible Assets
2,981.50
2,981.50
2,981.50
1,076.80
1,076.80
Total Assets
3,107.30
3,099.80
3,100.10
1,866.20
1,323.10
ST Debt & Current Portion LT Debt
1,585.60
1,197.30
1,210.30
2,108.90
3,861.20
Accounts Payable
543.20
563.70
596.40
405.00
-
Other Current Liabilities
1,009.70
1,051.40
1,366.70
3,820.80
1,967.90
Total Current Liabilities
3,138.50
2,812.50
3,173.40
6,334.60
5,829.10
Long-Term Debt
1,971.80
1,292.00
1,334.00
-
-
Total Liabilities
5,110.20
4,104.40
4,507.40
6,334.60
5,829.10
Common Equity (Total)
2,005.80
1,046.30
1,382.20
5,168.30
5,171.50
Total Shareholders' Equity
2,005.40
1,045.80
1,381.20
5,167.30
5,170.50
Total Equity
2,002.90
1,004.70
1,407.30
4,468.40
4,506.00
Liabilities & Shareholders' Equity
3,107.30
3,099.80
3,100.10
1,866.20
1,323.10
Accumulated Minority Interest
2.40
41.20
26.10
698.90
664.50
Preferred Stock (Carrying Value)
0.50
0.50
1.00
1.00
1.00
About VG Life Sciences
View Profile
